NNOX · Nano-X Imaging Ltd. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q4 '25 | Q4 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q4 '21 | Q3 '21 | Q4 '20 | Q4 '19 | Q4 '18 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | - | - | - | - | - |
| EPS - Basic | - | - | - | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q4 '25 | Q4 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q4 '21 | Q3 '21 | Q4 '20 | Q4 '19 | Q4 '18 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49.15M | $39.30M | $56.38M | $290.0K | $38.46M | $66.64M | - | $213.47M | $8.07M | $5.0K |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | $3.07M | $1.49M | $2.36M | - | - | $116.0K | - | - | - | - |
| Accounts Payable | $2.89M | $2.21M | $3.30M | - | $3.62M | $3.13M | - | $435.0K | $475.0K | - |
| Current Assets | $66.79M | $78.68M | $88.64M | - | $82.46M | $94.86M | - | $219.79M | $9.64M | - |
| Total Assets | $162.16M | $210.00M | $218.65M | - | $253.93M | $363.17M | - | $236.15M | $11.87M | - |
| Current Liabilities | $16.89M | $13.97M | $15.52M | - | $25.07M | $52.75M | - | $4.48M | $20.26M | - |
| Long-term Debt | - | - | - | - | $3.48M | - | $3.80M | - | - | - |
| Total Liabilities | $22.43M | $20.88M | $23.13M | - | $37.25M | $71.02M | - | $5.40M | $20.65M | - |
| Stockholders' Equity | $139.73M | $189.12M | $195.51M | - | $216.68M | $292.15M | - | $230.75M | ($8.78M) | ($6.38M) |
| Retained Earnings | ($448.77M) | ($373.75M) | ($320.23M) | - | ($259.46M) | ($146.21M) | - | ($84.42M) | ($40.60M) | - |
Cash Flow
| Line item | Q4 '25 | Q4 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q4 '21 | Q3 '21 | Q4 '20 | Q4 '19 | Q4 '18 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q4 '25 | Q4 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q4 '21 | Q3 '21 | Q4 '20 | Q4 '19 | Q4 '18 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | - | - | - | - | - | - | - | - | - | - |
| Return on equity | - | - | - | - | - | - | - | - | - | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 3.96 | 5.63 | 5.71 | - | 3.29 | 1.80 | - | 49.06 | 0.48 | - |
| Quick ratio | 3.77 | 5.52 | 5.56 | - | 3.29 | 1.80 | - | 49.06 | 0.48 | - |
| Cash ratio | 2.91 | 2.81 | 3.63 | - | 1.53 | 1.26 | - | 47.65 | 0.40 | - |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | 0.02 | - | - | - | - | - |
| Debt / Assets | - | - | - | - | 0.01 | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.16 | 1.11 | 1.12 | - | 1.17 | 1.24 | - | 1.02 | -1.35 | - |
| Liabilities / Assets | 0.14 | 0.10 | 0.11 | - | 0.15 | 0.20 | - | 0.02 | 1.74 | - |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Net income growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -26.1% | -3.3% | -9.8% | - | -25.8% | 26.6% | - | - | -37.5% | 22.8% |
Peer comparison
Same SIC group: X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Comparing Nano-X Imaging Ltd. against the 4 most active filers in the same SIC group.